Monoamine oxidase B (MAO-B) was recently identified as a member of the
family of imidazoline binding proteins, To localize the imidazoline b
inding domain on MAO-B, we labeled the domain with the imidazoline pho
toaffinity adduct [I-125]2-(3-azido-4-iodophenoxy)methylimidazoline in
rat and human liver and visualized labeled peptides by autoradiograph
y/sodium dodecyl sulfate-polyacrylamide gel electrophoresis after CNBr
cleavage of the labeled protein, Based on species-specific fragmentat
ion patterns and immunoprecipitation of labeled peptides, the imidazol
ine binding domain was localized to residues K149 to M222 of human MAO
-B. The imidazoline binding domain is encompassed within a region that
influences substrate processing but is distinct from primary sites of
interaction for the enzyme inhibitors pargyline and lazabemide (Ro 19
-6327). Radioligand binding assays and photoaffinity labeling also ind
icated that the various classes of compounds did not cross-compete at
the different enzyme domains. Identification of an imidazoline binding
domain on MAO-B provides a new opportunity for the potential pharmaco
logical development of imidazoline/guanidinium compounds and also pres
ents additional avenues for structure/function analysis of the monoami
ne oxidase enzymes.